457 related articles for article (PubMed ID: 22611308)
1. Clopidogrel and proton pump inhibitors--where do we stand in 2012?
Drepper MD; Spahr L; Frossard JL
World J Gastroenterol; 2012 May; 18(18):2161-71. PubMed ID: 22611308
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors and clopidogrel.
Gaglia MA; Waksman R
Cardiovasc Ther; 2010 Jun; 28(3):169-76. PubMed ID: 20345494
[TBL] [Abstract][Full Text] [Related]
3. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
Tran M; Tafreshi J; Pai RG
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037
[TBL] [Abstract][Full Text] [Related]
4. Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.
Johnson DA; Chilton R; Liker HR
Postgrad Med; 2014 May; 126(3):239-45. PubMed ID: 24918808
[TBL] [Abstract][Full Text] [Related]
5. Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.
Harvey A; Modak A; Déry U; Roy M; Rinfret S; Bertrand OF; Larose É; Rodés-Cabau J; Barbeau G; Gleeton O; Nguyen CM; Proulx G; Noël B; Roy L; Paradis JM; De Larochellière R; Déry JP
J Breath Res; 2016 Jan; 10(1):017104. PubMed ID: 26815196
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations.
Tantry US; Kereiakes DJ; Gurbel PA
JACC Cardiovasc Interv; 2011 Apr; 4(4):365-80. PubMed ID: 21511216
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
Laine L; Hennekens C
Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors and potential interactions with clopidogrel: an update.
Gerson LB
Curr Gastroenterol Rep; 2013 Jun; 15(6):329. PubMed ID: 23695547
[TBL] [Abstract][Full Text] [Related]
9. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
Hsiao FY; Mullins CD; Wen YW; Huang WF; Chen PF; Tsai YW
Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
Lettino M
Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections.
Laria A; Zoli A; Gremese E; Ferraccioli GF
Reumatismo; 2011 Mar; 63(1):5-10. PubMed ID: 21509344
[TBL] [Abstract][Full Text] [Related]
12. [Dilemma between gastroprotection and cardiovascular prevention].
Venerito M; Kandulski A; Malfertheiner P
Dtsch Med Wochenschr; 2010 Nov; 135(44):2193-8. PubMed ID: 20979006
[TBL] [Abstract][Full Text] [Related]
13. The clinical relevance of the clopidogrel-proton pump inhibitor interaction.
Mohammad A; Brilakis ES; Weideman RA; Little BB; Banerjee S
J Cardiovasc Transl Res; 2012 Aug; 5(4):547-52. PubMed ID: 22351048
[TBL] [Abstract][Full Text] [Related]
14. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
[TBL] [Abstract][Full Text] [Related]
15. [Interaction between clopidogrel and proton pump inhibitors].
Harmsze AM; de Boer A; Boot H; Deneer VH; Heringa M; Mol PG; Schalekamp T; Verduijn MM; Verheugt FW; le Comte M
Ned Tijdschr Geneeskd; 2011; 155(28):A2442. PubMed ID: 21771377
[TBL] [Abstract][Full Text] [Related]
16. Drug-drug interaction between clopidogrel and the proton pump inhibitors.
Norgard NB; Mathews KD; Wall GC
Ann Pharmacother; 2009 Jul; 43(7):1266-74. PubMed ID: 19470853
[TBL] [Abstract][Full Text] [Related]
17. Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials.
Dunn SP; Steinhubl SR; Bauer D; Charnigo RJ; Berger PB; Topol EJ
J Am Heart Assoc; 2013 Jan; 2(1):e004564. PubMed ID: 23525436
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
[TBL] [Abstract][Full Text] [Related]
19. Effects of rabeprazole on the antiplatelet effects and pharmacokinetics of clopidogrel in healthy volunteers.
Funck-Brentano C; Szymezak J; Steichen O; Ducint D; Molimard M; Remones V; Azizi M; Gaussem P
Arch Cardiovasc Dis; 2013 Dec; 106(12):661-71. PubMed ID: 24246616
[TBL] [Abstract][Full Text] [Related]
20. Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry.
Aihara H; Sato A; Takeyasu N; Nishina H; Hoshi T; Akiyama D; Kakefuda Y; Watabe H; Aonuma K;
Catheter Cardiovasc Interv; 2012 Oct; 80(4):556-63. PubMed ID: 22234956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
